5-hydroxytryptophan has been researched along with Coronary Heart Disease in 1 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lehnert, H | 1 |
| Lombardi, F | 1 |
| Raeder, EA | 1 |
| Lorenzo, AV | 1 |
| Verrier, RL | 1 |
| Lown, B | 1 |
| Wurtman, RJ | 1 |
1 other study available for 5-hydroxytryptophan and Coronary Heart Disease
| Article | Year |
|---|---|
Increased release of brain serotonin reduces vulnerability to ventricular fibrillation in the cat.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Blood Pressure; Carbidopa; Cats; Coron | 1987 |